V2 receptor — Drug Target
All drugs that target V2 receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
Vasopressin analogue · Vasopressin receptor antagonist · Vasopressin V2 receptor antagonist
Phase 3 pipeline (2)
- Terlipressin Injectable Product · Aga Khan University · Vasopressin analogue · Cardiovascular
Terlipressin is a synthetic analogue of vasopressin that acts as a potent vasoconstrictor. - Tolvaptan Tablets · Institute of Liver and Biliary Sciences, India · Vasopressin receptor antagonist · Cardiovascular
Tolvaptan is a selective, competitive antagonist of the vasopressin V2 receptor.
Phase 2 pipeline (1)
- BL - 1020 · BioLineRx, Ltd. · Vasopressin V2 receptor antagonist · Nephrology
BL-1020 is a vasopressin V2 receptor antagonist.